Skip to content
RecallWatchMedical Device Safety
Class IIOngoingZ-3206-2026

Howmedica Osteonics Corp. recalls SCORPIO C-DOME PATELLA 73-2710 73-2910 SCORPIO U-DOME PATELLA 73-3110 73-…

Howmedica Osteonics Corp.Mahwah, NJ, United StatesReported Sep 23, 2026 · 6 days ago
Legal News Analyst ·

Reason for recall

Affected devices were manufactured with Ultra High Molecular Weight Polyethylene (UHMWPE) raw material aged in excess of five years. Product has the potential for elevated levels of oxidation, which may result in increased wear, leading to hazards such as excessive wear debris, material fragments, fractured device, or disassociated device. Potential harms include revision surgery, pain, and inflammation.

Affected product

Check your device

Enter a lot, serial, REF, or UDI number from your device's label to check it against this recall's listed codes.

Affected products & lots

  • SCORPIO C-DOME PATELLA 73-2710 73-2910 SCORPIO U-DOME PATELLA 73-3110 73-3508 73-3708 73-3710 73-3910 Orthopaedic implant components manufactured from UHMWPE (polyethylene)
    UDI-DI 07613327033847
    39 affected lots
    73-29100761332703385414AGFD73-3110076133270338611L454JM57EL5
    +31 moreAME3MK74NTV7RE7J73-350807613327033885HMM573-37080761332703389234673D8DPMRHX1T6YJT9MEYAM773-3710076133270339083W2573-39100761332703391514NEYA1XED9Y3TD1M9D2YPEX8TKRT3KRT3X1T325V8X8X6YE

What the firm is doing

Firm began notifying customers on July 30, 2026, via FedEx 2-day air. Customers were instructed to quarantine and discontinue use of the affected product. Affected product should be returned to the firm.

DistributionShow details

Worldwide distribution - US Nationwide and the countries of Canada, LATAM, Europe, Asia Pacific, and South Africa.

Class IIWhat this means

Use of the product may cause temporary or medically reversible adverse health consequences.

Sources & references

Taylor Coteus
Legal News Analyst

Taylor Coteus is RecallWatch's Legal News Analyst, covering FDA medical-device enforcement and patient-safety litigation. He reviews every recall against the FDA's official openFDA record before it is published and is responsible for corrections and editorial accuracy.

More Class II recalls